Partnership Expands Access to Next-Generation Minimally Invasive Solution for Surgical Evacuation of Intracerebral Hemorrhage.

SAN JOSE, Calif. , Oct. 3, 2025 /PRNewswire/ -- Clearmind Biomedical, a leader in minimally invasive neurosurgical innovation, today announced it has signed an exclusive U.S. distribution agreement with Sutter Medical for the Neuroblade Multi-Function Neuro-Endoscope System, a 510(k)-cleared device engineered to advance the treatment of complex neurosurgical conditions such as intracerebral hemorrhage (ICH).

ICH remains one of the most devastating forms of stroke, with limited treatment options, high mortality, and severe disability rates. The Neuroblade system addresses this unmet need by providing neurosurgeons with a new paradigm for hemorrhage evacuation:

See Full Page